KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2025)

Historic Share-based Compensation for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $17.0 million.

  • Elanco Animal Health's Share-based Compensation rose 1333.33% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.0 million, marking a year-over-year increase of 2181.82%. This contributed to the annual value of $55.0 million for FY2024, which is 1956.52% up from last year.
  • As of Q3 2025, Elanco Animal Health's Share-based Compensation stood at $17.0 million, which was up 1333.33% from $20.0 million recorded in Q2 2025.
  • Elanco Animal Health's Share-based Compensation's 5-year high stood at $20.0 million during Q2 2025, with a 5-year trough of $9.0 million in Q2 2023.
  • Its 5-year average for Share-based Compensation is $14.6 million, with a median of $15.0 million in 2021.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 10000.0% in 2021, then crashed by 4705.88% in 2023.
  • Over the past 5 years, Elanco Animal Health's Share-based Compensation (Quarter) stood at $18.0 million in 2021, then dropped by 16.67% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then increased by 13.33% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $20.0 million for Q2 2025, and $15.0 million during Q1 2025.